New investment of £1.2M brings total Seed funding to £5.1M including Innovate UK grants of £1.9M Investment led by Cancer Research Horizons, the innovation engine at the core of Cancer Research UK Recent Innovate UK New Cancer Therapeutics grant award of £1.6M enables progression into development in collaboration with Cell…
News
Grant award of £1.6M supports program of development work with Cell and Gene Therapy Catapult • NK:IO’s platform, based on pioneering discoveries in NK cell biology, yields industry-leading tumour killing and cell production London, UK, 11 July 2023: NK:IO, a leader in NK cell biology applied to…
Keith Thompson is the current chair of biotech start-up NK:IO. He’s also chair of the Pharma Advisory Board of Deep Science Ventures and acted as industry advisor to the Vaccines Taskforce. Prior to this, Keith has had a rich career in biotech, with 8 years as CEO of The Cell…